Management Impact of 68 Ga-DOTATATE PET/CT in Neuroendocrine Tumors

ConclusionOur retrospective cohort demonstrated that68Ga-DOTATATE PET/CT improves lesion detection over conventional imaging in 33.3% and impacts the therapeutic management in 23.8% of patients with NET.

Source: Nuclear Medicine and Molecular Imaging - January 7, 2021 Category: Nuclear Medicine Source Type: research